15388 results for "1 mil coins fc 26 Visit Buyfc26coins.com for latest FC 26 coins news..buoc"

in 62.71 milliseconds.

• Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient

  Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004901

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004902

• Genome and transcriptome sequence data from a squamous cell lung carcinoma patient

  Genome and transcriptome sequence data from a squamous cell lung carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004903

• Genome and transcriptome sequence data from a metastatic gastric cancer patient

  Genome and transcriptome sequence data from a metastatic gastric cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004904

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004910

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004923

• Genome and transcriptome sequence data from a leiomyosarcoma patient

  Genome and transcriptome sequence data from a leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004922

• Genome and transcriptome sequence data from a meningioma patient

  Genome and transcriptome sequence data from a meningioma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004920

• Genome and transcriptome sequence data from a abdominal sarcoma patient

  Genome and transcriptome sequence data from a abdominal sarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004919

• Genome and transcriptome sequence data from a metastatic rectal cancer patient

  Genome and transcriptome sequence data from a metastatic rectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004918

• Genome and transcriptome sequence data from a metastatic melanoma patient

  Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004917

• Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient

  Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004916

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004915

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004914

• Genome and transcriptome sequence data from a metastatic pancreatic cancer patient

  Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004913

• Genome and transcriptome sequence data from a metastatic pancreatic cancer patient

  Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004912

• Genome and transcriptome sequence data from a metastatic colon cancer patient

  Genome and transcriptome sequence data from a metastatic colon cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004911

• Genome and transcriptome sequence data from a metastatic serous ovarian cancer patient

  Genome and transcriptome sequence data from a metastatic serous ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004909

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004908

• Genome and transcriptome sequence data from a T-cell prolymphocytic leukemia patient

  Genome and transcriptome sequence data from a T-cell prolymphocytic leukemia patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004907

• Genome and transcriptome sequence data from a diffuse large B-cell lymphoma patient

  Genome and transcriptome sequence data from a diffuse large B-cell lymphoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004906

• Genome and transcriptome sequence data from a metastatic adrenocortical carcinoma patient

  Genome and transcriptome sequence data from a metastatic adrenocortical carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004905

• Genome and transcriptome sequence data from a metastatic neuroendocrine tumor, lung primary patient

  Genome and transcriptome sequence data from a metastatic neuroendocrine tumor, lung primary patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004924

• Genome and transcriptome sequence data from a metastatic choroidal melanoma patient

  Genome and transcriptome sequence data from a metastatic choroidal melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004925

• Genome and transcriptome sequence data from a metastatic pancreatic cancer patient

  Genome and transcriptome sequence data from a metastatic pancreatic cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004926

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004927

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004928

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004929

• Genome and transcriptome sequence data from a metastatic ovarian cancer patient

  Genome and transcriptome sequence data from a metastatic ovarian cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004930

• Genome and transcriptome sequence data from a metastatic melanoma patient

  Genome and transcriptome sequence data from a metastatic melanoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004931

• Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic adenocarcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004932

• Genome and transcriptome sequence data from a metastatic sarcomatoid carcinoma of the lung patient

  Genome and transcriptome sequence data from a metastatic sarcomatoid carcinoma of the lung patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004933

• Genome and transcriptome sequence data from a oligometastatic colorectal cancer patient

  Genome and transcriptome sequence data from a oligometastatic colorectal cancer patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004935

• Genome and transcriptome sequence data from a metastatic rectal carcinoma patient

  Genome and transcriptome sequence data from a metastatic rectal carcinoma patient, generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001004936

• Genomic characterisation of MGUS

  The hematological malignancy multiple myeloma (MM), also called Kahler's disease or plasma cell (PC) myeloma, is characterized by a clonal expansion of PCs originating in the bone marrow (BM). The expansion of these cells leads to an overproduction of antibodies and results in typical symptoms such as anemia, renal failure and bone lesions. All cases of MM are preceded by the asymptomatic, non-malignant pre-stage monoclonal gammopathy of undetermined significance (MGUS). Of all MGUS patients, only 1% per year will progress to MM. Despite efforts to elucidate the molecular mechanisms underlying the MGUS-to-MM progression, its pathogenesis still remains largely unknown. Additionally, the genetic profiles of MGUS patients have only been limitedly investigated due to the only incidental finding of MGUS, the difficulties in BM sampling and isolating a sufficient number of aberrant PCs from the BM aspirates of MGUS patients. Consequently, reliable biomarkers to individually predict which MGUS patients will progress to MM and which will not, are lacking. Therefore, it is highly required to study the molecular pathogenesis of MGUS and the role of genetic events in relation to the malignant transformation to MM.

  Dataset EGAD00001006363

• Metabolic context regulates the competitive fitness of oncogenic PIK3CA mutant clones in the normal esophagus

  Activating mutations in PIK3CA generate large clones in the aging human esophagus. Here we investigate the underlying cellular mechanisms regulating their expansion by lineage tracing. Expression of an activating heterozygous Pik3caH1047R mutation in single progenitor cells of the mouse esophagus tilts cell fate towards proliferation, generating mutant clones that outcompete their wild type neighbours. The mutation leads to increased aerobic glycolysis through the activation of Hif1α transcriptional targets. In vitro and in vivo interventions that level out differences in activation of the PI3K/HIF1α/aerobic glycolysis axis between wild type and Pik3caH1047R cells attenuate the competitive advantage of the mutants. In contrast, metabolic conditions that alter Insulin/PI3K signalling, such as type-1 diabetes or diet-induced insulin resistance, further increase Pik3caH1047R mutant competitiveness in mice. Consistently, the density of activating PIK3CA mutations in human esophagus is increased in overweight individuals. We conclude that the metabolic environment influences the mutational landscape of normal epithelia. Clinically feasible interventions that even out signalling imbalances between wild type and mutant cells may therefore limit the expansion of oncogenic mutants in normal tissues.

  Dataset EGAD00001008281

• Distinct embryonic phylogenies and driver events of infant Wilms tumor - DNA

  Cancers of adults typically arise through progressive rounds of clonal diversification and intratumoral selective sweeps which generate a long mutational trunk with shorter subclonal branches. Here, we investigated whether tumors of young children exhibit the same phylogenetic configuration. We studied three infants, including two newborns, with the childhood kidney cancer, Wilms tumour, through whole genome sequencing of bulk tissues, of single cell derived organoids, and of microdissections. All three cancers exhibited unusual driver events, with tumours of newborns harbouring FOXR2 rearrangements, delineating a distinct variant of Wilms tumour. Phylogenetic analyses suggest that tumors were seeded in an early, possibly confined window of development. Unusually, following seeding there was extensive polyclonal diversification with little evidence of clonal sweeps, leading to a distinct phylogenetic configuration more reminiscent of normal tissues rather than of adult cancers. These findings indicate that some childhood cancers may diversify via unorthodox phylogenetic pathways.

  Dataset EGAD00001009812

• Targeted capture ctDNA Library CRCQV40Run027-7

  Targeted capture ctDNA Library CRCQV40Run027-7 from patient PBC0003364, saliva sample

  Dataset EGAD00001010396

• Targeted capture ctDNA Library CRCQV40Run027-8

  Targeted capture ctDNA Library CRCQV40Run027-8 from patient PBC0004076, saliva sample

  Dataset EGAD00001010397

• Targeted capture ctDNA Library CRCQV40Run027-9

  Targeted capture ctDNA Library CRCQV40Run027-9 from patient PBC0004350, saliva sample

  Dataset EGAD00001010398

• Targeted capture ctDNA Library CRCQV42Run016-11

  Targeted capture ctDNA Library CRCQV42Run016-11 from patient PBC0001467, plasma baseline sample

  Dataset EGAD00001010399

• Targeted capture ctDNA Library CRCQV42Run016-16

  Targeted capture ctDNA Library CRCQV42Run016-16 from patient PBC0001396, saliva sample

  Dataset EGAD00001010400

• Targeted capture ctDNA Library CRCQV42Run016-17

  Targeted capture ctDNA Library CRCQV42Run016-17 from patient PBC0001467, saliva sample

  Dataset EGAD00001010401

• Targeted capture ctDNA Library CRCQV42Run016-9

  Targeted capture ctDNA Library CRCQV42Run016-9 from patient PBC0001396, plasma baseline sample

  Dataset EGAD00001010402

• Targeted capture ctDNA Library CRCQV42Run017-10

  Targeted capture ctDNA Library CRCQV42Run017-10 from patient PBC0002255, plasma 12 month sample

  Dataset EGAD00001010403

• Targeted capture ctDNA Library CRCQV42Run017-11

  Targeted capture ctDNA Library CRCQV42Run017-11 from patient PBC0001845, plasma 6 month sample

  Dataset EGAD00001010404

• Targeted capture ctDNA Library CRCQV42Run017-12

  Targeted capture ctDNA Library CRCQV42Run017-12 from patient PBC0002429, plasma 9 month sample

  Dataset EGAD00001010405

• Targeted capture ctDNA Library CRCQV42Run017-13

  Targeted capture ctDNA Library CRCQV42Run017-13 from patient PBC0002383, plasma 12 month sample

  Dataset EGAD00001010406

• Targeted capture ctDNA Library CRCQV42Run017-15

  Targeted capture ctDNA Library CRCQV42Run017-15 from patient PBC0001673, plasma 24 month sample

  Dataset EGAD00001010407

• Targeted capture ctDNA Library CRCQV42Run017-16

  Targeted capture ctDNA Library CRCQV42Run017-16 from patient PBC0002816, plasma 6 month sample

  Dataset EGAD00001010408

• Targeted capture ctDNA Library CRCQV42Run017-17

  Targeted capture ctDNA Library CRCQV42Run017-17 from patient PBC0002062, plasma 6 month sample

  Dataset EGAD00001010409

• Targeted capture ctDNA Library CRCQV42Run017-18

  Targeted capture ctDNA Library CRCQV42Run017-18 from patient PBC0002294, plasma 12 month sample

  Dataset EGAD00001010410

• Targeted capture ctDNA Library CRCQV42Run017-19

  Targeted capture ctDNA Library CRCQV42Run017-19 from patient PBC0001432, plasma 18 month sample

  Dataset EGAD00001010411

• Targeted capture ctDNA Library CRCQV42Run017-20

  Targeted capture ctDNA Library CRCQV42Run017-20 from patient PBC0001051, plasma 18 month sample

  Dataset EGAD00001010412

• Targeted capture ctDNA Library CRCQV42Run017-22

  Targeted capture ctDNA Library CRCQV42Run017-22 from patient PBC0001627, plasma 6 month sample

  Dataset EGAD00001010413

• Targeted capture ctDNA Library CRCQV42Run017-8

  Targeted capture ctDNA Library CRCQV42Run017-8 from patient PBC0001224, plasma 15 month sample

  Dataset EGAD00001010415

• Targeted capture ctDNA Library CRCQV42Run017-9

  Targeted capture ctDNA Library CRCQV42Run017-9 from patient PBC0001255, plasma 18 month sample

  Dataset EGAD00001010416

• Targeted capture ctDNA Library CRCQV42Run018-20

  Targeted capture ctDNA Library CRCQV42Run018-20 from patient PBC0001859, saliva sample

  Dataset EGAD00001010418

• Targeted capture ctDNA Library CRCQV42Run019-12

  Targeted capture ctDNA Library CRCQV42Run019-12 from patient PBC0001295, plasma baseline sample

  Dataset EGAD00001010419

• Targeted capture ctDNA Library CRCQV42Run019-14

  Targeted capture ctDNA Library CRCQV42Run019-14 from patient PBC0001304, plasma baseline sample

  Dataset EGAD00001010420

• Targeted capture ctDNA Library CRCQV42Run019-18

  Targeted capture ctDNA Library CRCQV42Run019-18 from patient PBC0001295, saliva sample

  Dataset EGAD00001010421

• Targeted capture ctDNA Library CRCQV42Run020-10

  Targeted capture ctDNA Library CRCQV42Run020-10 from patient PBC0001315, plasma baseline sample

  Dataset EGAD00001010425

• Targeted capture ctDNA Library CRCQV42Run020-14

  Targeted capture ctDNA Library CRCQV42Run020-14 from patient PBC0001312, saliva sample

  Dataset EGAD00001010426

• Targeted capture ctDNA Library CRCQV42Run020-15

  Targeted capture ctDNA Library CRCQV42Run020-15 from patient PBC0001315, saliva sample

  Dataset EGAD00001010427

• Targeted capture ctDNA Library CRCQV42Run020-23

  Targeted capture ctDNA Library CRCQV42Run020-23 from patient PBC0001310, saliva sample

  Dataset EGAD00001010428

• Targeted capture ctDNA Library CRCQV42Run020-24

  Targeted capture ctDNA Library CRCQV42Run020-24 from patient PBC0001310, plasma baseline sample

  Dataset EGAD00001010429

• Targeted capture ctDNA Library CRCQV42Run020-9

  Targeted capture ctDNA Library CRCQV42Run020-9 from patient PBC0001312, plasma baseline sample

  Dataset EGAD00001010432

• Targeted capture ctDNA Library CRCQV42Run021-13

  Targeted capture ctDNA Library CRCQV42Run021-13 from patient PBC0001299, plasma baseline sample

  Dataset EGAD00001010436

• Targeted capture ctDNA Library CRCQV42Run021-15

  Targeted capture ctDNA Library CRCQV42Run021-15 from patient PBC0001323, plasma baseline sample

  Dataset EGAD00001010437

• Targeted capture ctDNA Library CRCQV42Run021-17

  Targeted capture ctDNA Library CRCQV42Run021-17 from patient PBC0001516, plasma baseline sample

  Dataset EGAD00001010439

• Targeted capture ctDNA Library CRCQV42Run021-18

  Targeted capture ctDNA Library CRCQV42Run021-18 from patient PBC0001653, plasma baseline sample

  Dataset EGAD00001010440

• Targeted capture ctDNA Library CRCQV42Run021-19

  Targeted capture ctDNA Library CRCQV42Run021-19 from patient PBC0001299, saliva sample

  Dataset EGAD00001010441

• Targeted capture ctDNA Library CRCQV42Run021-21

  Targeted capture ctDNA Library CRCQV42Run021-21 from patient PBC0001323, saliva sample

  Dataset EGAD00001010442

• Targeted capture ctDNA Library CRCQV42Run021-22

  Targeted capture ctDNA Library CRCQV42Run021-22 from patient PBC0001470, saliva sample

  Dataset EGAD00001010443

• Targeted capture ctDNA Library CRCQV42Run021-23

  Targeted capture ctDNA Library CRCQV42Run021-23 from patient PBC0001516, saliva sample

  Dataset EGAD00001010444

• Targeted capture ctDNA Library CRCQV42Run021-24

  Targeted capture ctDNA Library CRCQV42Run021-24 from patient PBC0001653, saliva sample

  Dataset EGAD00001010445

• Targeted capture ctDNA Library CRCQV42Run026-4

  Targeted capture ctDNA Library CRCQV42Run026-4 from patient PBC0002872, plasma baseline sample

  Dataset EGAD00001010496

• Targeted capture ctDNA Library CRCQV42Run026-5

  Targeted capture ctDNA Library CRCQV42Run026-5 from patient PBC0003014, plasma baseline sample

  Dataset EGAD00001010497

• Targeted capture ctDNA Library CRCQV42Run026-6

  Targeted capture ctDNA Library CRCQV42Run026-6 from patient PBC0003595, plasma baseline sample

  Dataset EGAD00001010498

• Targeted capture ctDNA Library CRCQV42Run026-9

  Targeted capture ctDNA Library CRCQV42Run026-9 from patient PBC0003385, plasma baseline sample

  Dataset EGAD00001010499

• Targeted capture ctDNA Library CRCQV42Run028-10

  Targeted capture ctDNA Library CRCQV42Run028-10 from patient PBC0003587, plasma baseline sample

  Dataset EGAD00001010500

• Targeted capture ctDNA Library CRCQV42Run028-11

  Targeted capture ctDNA Library CRCQV42Run028-11 from patient PBC0003643, plasma baseline sample

  Dataset EGAD00001010501

• Targeted capture ctDNA Library CRCQV42Run028-12

  Targeted capture ctDNA Library CRCQV42Run028-12 from patient PBC0004076, plasma baseline sample

  Dataset EGAD00001010502

• Targeted capture ctDNA Library CRCQV42Run028-13

  Targeted capture ctDNA Library CRCQV42Run028-13 from patient PBC0004414, plasma baseline sample

  Dataset EGAD00001010503

• Targeted capture ctDNA Library CRCQV42Run028-14

  Targeted capture ctDNA Library CRCQV42Run028-14 from patient PBC0004565, plasma baseline sample

  Dataset EGAD00001010504

• Targeted capture ctDNA Library CRCQV42Run028-16

  Targeted capture ctDNA Library CRCQV42Run028-16 from patient PBC0005064, plasma baseline sample

  Dataset EGAD00001010505

• Targeted capture ctDNA Library CRCQV42Run028-17

  Targeted capture ctDNA Library CRCQV42Run028-17 from patient PBC0005116, plasma baseline sample

  Dataset EGAD00001010506

• Targeted capture ctDNA Library CRCQV42Run028-20

  Targeted capture ctDNA Library CRCQV42Run028-20 from patient PBC0002533, plasma baseline sample

  Dataset EGAD00001010507

• Targeted capture ctDNA Library CRCQV42Run028-23

  Targeted capture ctDNA Library CRCQV42Run028-23 from patient PBC0002533, saliva sample

  Dataset EGAD00001010508

• Targeted capture ctDNA Library CRCQV42Run028-4

  Targeted capture ctDNA Library CRCQV42Run028-4 from patient PBC0001335, plasma baseline sample

  Dataset EGAD00001010509

• Targeted capture ctDNA Library CRCQV42Run028-9

  Targeted capture ctDNA Library CRCQV42Run028-9 from patient PBC0003364, plasma baseline sample

  Dataset EGAD00001010510

• Targeted capture ctDNA Library CRCQV42Run029-12

  Targeted capture ctDNA Library CRCQV42Run029-12 from patient PBC0004173, plasma baseline sample

  Dataset EGAD00001010512

• Targeted capture ctDNA Library CRCQV42Run029-16

  Targeted capture ctDNA Library CRCQV42Run029-16 from patient PBC0001353, plasma baseline sample

  Dataset EGAD00001010513

• Targeted capture ctDNA Library CRCQV42Run029-17

  Targeted capture ctDNA Library CRCQV42Run029-17 from patient PBC0004173, saliva sample

  Dataset EGAD00001010514

• Targeted capture ctDNA Library CRCQV42Run029-21

  Targeted capture ctDNA Library CRCQV42Run029-21 from patient PBC0001353, saliva sample

  Dataset EGAD00001010515

• Targeted capture ctDNA Library CRCQV42Run029-23

  Targeted capture ctDNA Library CRCQV42Run029-23 from patient PBC0004350, plasma baseline sample

  Dataset EGAD00001010516

• Targeted capture ctDNA Library CRCQV42Run029-24

  Targeted capture ctDNA Library CRCQV42Run029-24 from patient PBC0003334, plasma 3 month sample

  Dataset EGAD00001010517

• Targeted capture ctDNA Library CRCQV42Run030-14

  Targeted capture ctDNA Library CRCQV42Run030-14 from patient PBC0001315, buffy coat sample

  Dataset EGAD00001010520

• Targeted capture ctDNA Library CRCQV42Run030-15

  Targeted capture ctDNA Library CRCQV42Run030-15 from patient PBC0003014, buffy coat sample

  Dataset EGAD00001010521

• Targeted capture ctDNA Library CRCQV42Run030-19

  Targeted capture ctDNA Library CRCQV42Run030-19 from patient PBC0001323, buffy coat sample

  Dataset EGAD00001010522